MedTrace Logo

Characteristics of Episodic Ataxia Syndrome

NCT00266760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2023-05-15

No results posted yet for this study

Summary

Episodic ataxia (EA) is a rare genetic disease characterized by episodes of imbalance, incoordination, and slurring of speech. The underlying cause of EA is only partly understood, and currently there are no established treatments. There is also little information about the link between EA's clinical features and its genetic basis. The purpose of this study is to better characterize EA and disease progression. In turn, this may direct the development of future treatments.

Conditions

  • Episodic Ataxia Syndrome
  • Cerebellar Diseases

Sponsors & Collaborators

Principal Investigators

  • Robert W. Baloh, MD · University of California, Los Angeles

  • Joanna C. Jen, MD, PhD · University of California, Los Angeles

  • Tracey Graves, MD · Institute of Neurology and National Hospital for Neurology

  • Yoon-Hee Cha, MD · University of California, Los Angeles

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States
  • Canada
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00266760 on ClinicalTrials.gov